Zhu Xiaoyu, Jiang Lili, Long Mengtuan, Wei Xuejiao, Hou Yue, Du Yujun
Department of Nephrology, The First Hospital of Jilin University, Changchun, China.
Physical Examination Center, The First Hospital of Jilin University, Changchun, China.
Front Med (Lausanne). 2021 Nov 8;8:746920. doi: 10.3389/fmed.2021.746920. eCollection 2021.
There are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, and function, but metabolic abnormalities can lead to pathological changes. Normal energy metabolism is particularly important for maintaining the structure and function of the kidneys because they consume large amounts of energy. We describe the metabolic reprogramming that occurs during renal fibrosis, which includes changes in fatty acid metabolism and glucose metabolism, and the relationship of these changes with renal fibrosis. We also describe the potential role of novel drugs that disrupt this metabolic reprogramming and the development of fibrosis, and current and future challenges in the treatment of fibrosis.
慢性肾脏病有多种病因,但所有这些患者都存在肾纤维化。尽管许多研究已对肾纤维化的发病机制进行了探究,但仍没有有效的治疗方法。健康且平衡的代谢对于正常细胞的生长、增殖及功能而言是必要的,然而代谢异常会引发病理变化。正常的能量代谢对于维持肾脏的结构和功能尤为重要,因为肾脏消耗大量能量。我们阐述了肾纤维化过程中发生的代谢重编程,其中包括脂肪酸代谢和葡萄糖代谢的变化,以及这些变化与肾纤维化的关系。我们还描述了破坏这种代谢重编程及纤维化发展的新型药物的潜在作用,以及纤维化治疗中当前和未来面临的挑战。